1 Motivation 2 Hyperploidy and segmental aneuploidy are hallmarks of cancer cells due to chromosome 3 segregation errors and genomic instability. In such situations, accurate aneuploidy profiling 4 of cancer data is critical for calibration of copy number (CN)-detection tools. Additionally, 5 cancer cell populations suffer from different levels of clonal heterogeneity and aneuploidy 6 alterations over time. The degree of heterogeneity adversely affects the segregation of the 7 depth of coverage (DOC) signal into integral CN states. This, in turn, strongly influences the 8 reliability of this data for ploidy profiling and copy number variation (CNV) analysis. 9
Introduction 1
Cancer cells are plagued with microscopic and submicroscopic numerical and structural 2 alterations of chromosomes. Chromosome missegregation and instability manifests in 3 complex genetic makeups of cancer cells. They can simultaneously acquire near-polyploidy 4 state or aneuploidy at whole-chromosome or portions (segments) of chromosomes [1, 2] . As 5 a result, cancer cells frequently have polyploidy or hyperploidy profiles with widespread 6 segmental aneuploidies [3] [4] [5] . Analysis of the Mitelman database indicates 86% of solid 7 tumors and 72% of blood cancers exhibit whole-chromosome gain or loss, while 26% and 6% 8 of them are near-polyploid, respectively [6] . Also, profiles of 47 ovarian cancer cell lines 9 from the CCLE database showed that up to 74% of their genomes are altered [7] . 10 Furthermore, cancer cell populations are genetically highly heterogeneous. Sometimes they 11 remain stable with aneuploid karyotype, and in other times, they undergo continuous genetic 12 alterations over passaging time and culture conditions [8] . Same cell line cultured in different 13 labs exhibits karyogram changes [9] . These facts suggest that cancer cells undergo an 14 adaptive and evolutionary process even under controlled culture environment to generate 15 clonal variability at copy number, gene expression and phenotypic levels [10] . Taken 16 together, all these alterations give rise to 'mosaic' karyotypes of cancer cell populations. 17 Ploidy information is associated with cancer progression and their varied sensitivity to 18 chemotherapy. Aneuploidy, in general, is considered as a marker of poor prognosis and their 19 presence correlates with chemoresistance [11] . In fact, antiproliferative compounds targeting 20 aneuploid cells serve as a new chemotherapeutic strategy for cancer cells [12] . Furthermore, 21 characterization of the aneuploidy profile forms the basis of CNV detection for single-sample 22 cancer data [13] . Most read depth (RD)-based tools use the global RD median for setting the 23 CN reference (2N) [14, 15] or the ploidy states [16, 17] . However, the global median may not 24 accurately approximate any of the ploidy states, especially in case of hyperploid cancer cells. 25 Moreover, some of these tools require the information of CN gain/loss percentage for better 26 modeling of the RD signal. Therefore, it is necessary to estimate the overwhelming extent of 27 aneuploidy spectrum for calibrating the CNV detection tools. 28 The chromosomal aneuploidy and microscopic-level segmental gain or loss are classically 29 analyzed by karyotyping. Deviation from 'normal' karyotype is a common hallmark of 30 cancer cells [18, 19] . Whole-genome ploidy level with modal chromosome number has been 31 routinely characterized for most cancer cell lines using imaging techniques by individual labs 32 and cell repositories. However, cancer cells undergo clonal evolution over time and therefore 33 ploidy characterization may not be stable and reliable. Moreover, karyotyping is a low-34 resolution technique. Therefore, standard karyotype cannot distinguish between two genomes 35 with normal chromosome complement but harboring different submicroscopic chromosomal 36 aneuploidies. Taken together, the dynamics of these microscopic and submicroscopic 37 alterations represents timestamp 'barcode' of aneuploidy spectrum of cancer cells. A rough 38 estimation of this spectrum can form the background knowledge needed for accurate 39 downstream sequence analysis of cancer cell line.
40
The advent of array-and next-generation sequencing (NGS)-based techniques allowed 41 higher-resolution estimation of the complete repertoire of aneuploidy at different structural 42 levels. Most genome-level ploidy tools compute ploidy levels by assessing the distribution of 43 allele frequency at biallelic single-nucleotide polymorphisms (SNPs) [20] [21] [22] . These SNP-44 based tools require very high-coverage sequencing data. As a result, they were successfully 45 applied to small genomes like yeast but are less adaptable in human scenario, especially for 46 low-coverage sequencing data. Additionally, PloidyNGS estimates ploidy by assuming 47 different ratios of biallelic SNPs at different ploidy levels. However, this can bring ambiguity 48 in defining the diploid versus tetraploid with 0.5/0.5 ratios. Recently, nQuire was developed 49 to estimate ploidy by fitting the coverage signal to pre-determined frequency distributions 50 with fixed contribution from each ploidy state [23] . Nevertheless, nQuire cannot capture the 51 hyperploidy profiles which have variable combinations of different ploidy levels. Hence, it is 52 necessary to capture the contribution of each ploidy level into the complete aneuploidy 53 profile (aneuploidy spectrum) without any pre-defined assumption of whole-genome ploidy.
54
Additionally, ploidy tools are implicitly built on a fundamental assumption that cancer cell 55 lines are clonal in origin, and therefore, they are 'homogeneous' in nature. The pervasive 56 presence of cellular variability and genetic heterogeneity in cancer cells [24] necessitate 57 estimating the homogeneity level in cancer population as a condition for accurate ploidy 58 estimation.
59
Here, we introduce AStra (Aneuploidy Spectrum (detection) through read depth analysis), a 60 Python-based software for capturing the complete aneuploidy profile of cancer genome 61 without an explicit assumption of the ploidy level of the input sequencing data. AStra is 62 based on the fundamental reasoning that most genomic segments belong to integral CN 63 states. AStra scans the RD signal to find the CN reference that best segregates genomic 2. Methods 1 2.1 AStra framework 2 AStra utilizes the RD signal of the input data to define its aneuploidy spectrum and to 3 compute its important features for accurate ploidy and CNV analysis. The main key for 4 defining the aneuploidy spectrum is the accurate estimation of CN reference (2N) by 5 scanning the RD signal. CN reference should be defined as the RD value that segregates RD 6 signal distribution into segments of integral CN states. In our pipeline, NGS reads are used 7 first to compute the RD signal. This RD signal is clustered using Pruned Exact Linear Time 8 (PELT) method [25] into primary segments of different RD values. Then, we employ 10 9 different unimodal/multimodal distributions to define the candidate CN references and the 10 associated CN states ( Fig. 1a ). Under each candidate reference, we merge the adjacent 11 primary segments with same CN state into large contiguous segment to generate the 12 aneuploidy profile. Then, we compute the Centralization Error (CE) of that aneuploidy 13 profile as the weighted summation of differences between the estimated CN of segments and 14 their CN states (Fig. 1b ). The correct CN reference is the one that achieves the minimum CE.
15
Once the CN reference is settled, we compute the ploidy spectrum as the percentages of each 16 ploidy level into the complete aneuploidy profile. Finally, the homogeneity score (HS) is 17 calculated as the percentage of genomic segments with estimated CN around their integral 18 CN states ( Fig. 1c ). We also define the whole-genome ploidy ('diploid,' 'triploid,' or 19 'tetraploid') and determine the validity of usage of the global median (RD signal) as CN 20 reference. where i is the copy-number state (2, 3, 4, 5, 6), is the weight of the Gaussian distribution 34 at state i (0, 1, 0.5, 0.25, 0.125, 0.0625) and c is a constant for normalization of the 35 probability distribution function. The standard deviation (σ) is 0.5/3 to make 0 at the 36 boundaries of copy-number intervals (1.5, 2.5, 3.5, …). analyses based on its coverage and heterogeneity level. Therefore, we introduced the 16 homogeneity score (HS) to evaluate the degree of separation between different copy number 17 states (peaks) of the cancer data.
18
We analyzed low-coverage (< 3x) sequencing data of 20 cancer cell line data with a total of 19 31 replicates ( Supplementary Table 1 ). We found that HS is weakly correlated with the 20 coverage of the data (Spearman correlation = -0.3104, p-value= 0.0658) ( Fig. 2a ).
21
Interestingly, we found that HS varies considerably among biological replicates from the 22 same laboratory as well as among the same cell line sequencing data from different studies. Table 2 ). Also, HS is not affected by the whole genome ploidy 34 level (Fig. 2b) . Therefore, we concluded that coverage cannot be used as an absolute 35 threshold to assess the suitability of cancer data for copy number analysis. We found that 36 sequencing data with higher HS are less affected by the biases of cancer genomes. After 37 examining all the datasets, we concluded that a minimum homogeneity score of 75% profiles. In such a case, we recommend checking the aneuploidy spectrum manually.
45
Therefore, we argue that homogeneity scoring should be a prerequisite test to be performed 46 on every sequencing data before downstream CNV and aneuploidy analyses. distribution with most genomic segments distributed around the integral copy number states.
54
For that, AStra examines many multimodal distributions with different weights of CN states 55 to define the candidate CN reference. CN reference is chosen based on the model that best 56 assimilates the genomic segments (and not RD fitting) into distinct peaks of multimodal 57 distribution. This allows us to apply AStra on low-coverage data and ignore the adverse 58 effects of signal dispersion. 59 We applied AStra for 36 samples of low-coverage cancer cells, A427 high-coverage cancer 60 cell, and 3 high-coverage normal cells ( Supplementary Table 1 ). AStra computes the 61 aneuploidy profile of low-coverage (<3x) data in less than 3 minutes and high-coverage (28x) 62 in about 15 minutes ( Supplementary Table 1 ). Astra successfully identified the accurate 63 aneuploidy spectrum of all cell lines, with HS greater than 75%, based on two conditions.
64
First, copy number reference and higher CN states are detected as peaks of multimodal distribution ( Fig. 2b, Supplementary Fig. 2 ). Second, the major peak confirms the known 66 karyotype for the ploidy cells ( Supplementary Table 1 ). Similarly, the two major peaks 67 confirm the known karyotype for the hyperploidy cells ( Supplementary Table 1 ). For 68 example, AStra detected the location four peaks (1N, 2N, 3N, 4N ) accurately of VCaP at both 69 10Kb and 100Kb bins (Fig. 2b) . Although the RD-frequency of VCaP at 10Kb can be 70 wrongly interpreted as unimodal distribution, AStra still can identify the accurate values of 71 CN states.
72
We then analyzed the performance of our 10 empirical models for estimating the aneuploidy 73 spectrum by comparing their CEs on different datasets. We also counted the number of 74 datasets that has minimum CE using each model. We found that 9 out of the 10 models 75 results in the minimum CE for at least one dataset (Fig. 2c) . M4, M10, and M1 show the best 76 performance as they gave the minimum CE for 5, 5 and 4 datasets, respectively. Remarkably,
77
there is at least one additional model that results in similar CE (<5% difference) for each 78 dataset ( Fig. 2d ). Therefore, it confirms our hypothesis that aneuploidy spectrum of cancer 79 cells cannot be comprehended based on a single empirical model for each ploidy level. As a 80 conclusion, our models allow AStra to detect the aneuploidy profiles of hyperploidy cancer 81 cells. 83 We have also benchmarked our tool against nQuire by applying it on 10 cancer cell lines with 84 known karyotype information and 3 normal cell lines ( Supplementary Table 3 ). This error can be used to check the validity of ploidy assumption (Fig. 3a ). If this 117 error is large (Fig. 3b) , the only solution is to correct the copy number of the CNV regions.
82

AStra best estimates the whole-genome ploidy in low-coverage WGS data
118
This can be achieved by computing CN correction factor as the ratio between ploidy state and 119 the global median ( Supplementary Table 1 ). User can use this ratio to adjust the CN of output 120 segments of the tool. Based on these observations, it can be concluded that knowledge of 121 aneuploidy spectrum is fundamental for selecting and calibrating CNV detection tools. aneuploidy is associated with uncontrolled cellular growth and cancer [32] . Majority of all 128 human solid tumors carry numerical changes in karyotype [33] . Mouse models of 129 chromosome instability indicate that aneuploidy is directly responsible for cancer formation 130 [34, 35] . In order to understand the effect of aneuploidy profile change on the phenotype of 131 cancer cells, we revisited the study of 27 strains of MCF7 cell lines to obtain the sequencing 132 data [10] . 133 We applied AStra on all the 27 strains of MCF7 collected from different labs (Supplementary 134 5N and 3.5N ).
138
Interestingly, we also found that strain Z has HS of 65% which is lower than our empirically 139 estimated threshold of >75%. The ploidy levels of the rest 26 strains are inferred as 7 triploid 140 and 19 tetraploid based on the CN state with the maximum percentage of genomic segments 141 ( Supplementary Fig. 3 ). This confirms the idea that populations of the same cell line may 142 have different ploidy profiles based on the culture condition and passage number. Moreover,
143
we found that HS varies greatly among the 26 strains from 56% to 96% with only 14 strains 144 achieving our cutoff threshold of >75% (Fig. 3c) . The other 12 strains with low HS suffer 145 from a higher degree of heterogeneity. The RD signal of these heterogeneous strains shows a 146 strong effect of wave artifacts and dispersion ( Supplementary Fig. 3d-e ). Remarkably, we 147 found that the homogeneity score is correlated with the doubling time (Spearman correlation 148 = 0.7718, p-value = 2.4215e-06) (Fig. 3d) reported earlier for these strains [10] . Additionally, 149 11 strains (viz. A, F, R, S, T, U, V, W, X, Y, and Z) form one group of similar HS and data 150 coverage (Fig. 3c) . These same strains were grouped under one cluster in the earlier study 151 based on their SNV (single nucleotide variant) cellular prevalence [10] . This suggests that 152 homogeneity score itself is informative beside the aneuploidy spectrum information.
Discussion
1
The genetic profiling of cancer cells is complex. The alterations at the numerical and 2 structural levels and at multitude of length-scales are difficult to detect using a single and visual inspection of the results suggest that a minimum homogeneity score of 75% can be 20 used as a confidence threshold for downstream estimation of ploidy profile.
21
In conclusion, we recommend using AStra results as a quick reference guide to assess the 
